Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹63.7 Cr 36.9% 0.9% -44.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹5,974.9 Cr -0.3% -11.5% -21.4% Stock Analytics
KIRI INDUSTRIES ₹2,263.5 Cr 7.6% -13.3% -40.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,525.8 Cr 15.1% 0.2% -25.2% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,054.2 Cr 5.2% 5.8% 20.2% Stock Analytics
BODAL CHEMICALS ₹760.3 Cr 5.7% 29.9% -7.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

36.9%

0.9%

-44.3%

SENSEX

-1.6%

-8.8%

-4.1%


You may also like the below Video Courses